Answers are grounded in this paper and cite their sources.
To the Editor: I must comment on the paper of Lysakowski et al. (1). This study was neither appropriately randomized nor was a valid assessment of the cost/benefit ratio made. The authors used saline as a placebo, without realizing that its pH is too acid and therefore irritates the skin, which is confirmed by the pain score NVS 4.2 in the saline and 3.9 in the nontreatment group. The commonly used 25-gauge needle/syringe should have been utilized in the control group. The major cause of the poor results is the lack of buffering the lidocaine. There are multiple misstatements of costs in their article, e.g., $23.00 for 1% lidocaine in the Abstract and $4.69 in Table 2, $10.00 for the 2% in the Abstract and $4.82 in Table 2. Their findings are contrary to published reports (2–4) that with jet injection of midazolam, ketamine, and lidocaine, none of the children or adults experienced pain greater than 1 on a visual analog scale. During the past 3 years, in over 100,000 jet-local anesthesia injections, zero pain scores were consistently observed in our hospital. Furthermore, our cost of skin local anesthesia with the J-tip syringe is matching the combined cost of a safety needle and syringe. Elemer K. Zsigmond, MD, DSc Director of NIPF UICH Project, University of Illinois Medical Center, Chicago, IL
No takes yet. Share an insight, caveat, or question.
Elemér K. Zsigmond (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: